Summary Phosphoinositide-3-kinase (PI3K)-α inhibitors have shown clinical activity in squamous carcinoma (SCC) of head and neck (H&N) bearing PIK3CA mutations or amplification. Studying models of therapeutic resistance we have observed that SCCs cells that become refractory to PI3Kα inhibition maintain PI3K-independent activation of the mammalian target of rapamycin (mTOR). This persistent mTOR activation is mediated by the tyrosine kinase receptor AXL. AXL is overexpressed in resistant tumors from both laboratory models and patients treated with the PI3Kα inhibitor BYL719. AXL dimerizes with and phosphorylates epidermal growth factor receptor (EGFR), resulting in activation of phospholipase Cγ (PLCγ)- protein kinase C (PKC), which in turn activates mTOR. Combined treatment with PI3Kα and either EGFR, AXL, or PKC inhibitors reverts this resistance.

In this work, Mn-MOF-74 with hollow spherical structure and Co-MOF-74 with petal-like shape have been prepared successfully via the hydrothermal method. The catalysts were characterized using X-ray diffraction (XRD), Fourier transform infrared spectroscopy (FT-IR), thermogravimetry-mass spectrum analysis (TG-MS), N adsorption/desorption, scanning electron microscopy (SEM), and X-ray photoelectron spectroscopy (XPS). It is found that MOF-74(Mn, Co) exhibits the capability for selective catalytic reduction (SCR) of NO at low temperatures. Both experimental (temperature-programmed desorption, TPD) and computational methods have shown that Co-MOF-74 and Mn-MOF-74 owned high adsorption and activation abilities for NO and NH. The catalytic activities of Mn-MOF-74 and Co-MOF-74 for low-temperature denitrification (deNO) in the presence of NH were 99% at 220 °C and 70% at 210 °C, respectively. It is found that the coordinatively unsaturated metal sites (CUSs) in M-MOF-74 (M = Mn and Co) played important roles in SCR reaction. M-MOF-74 (M = Mn and Co), especially Mn-MOF-74, showed excellent catalytic performance for low-temperature SCR. In addition, in the reaction process, NO conversion on Mn-MOF-74 decreased with the introduction of HO and SO and almost recovered when gas was cut off. However, for Co-MOF-74, SO almost has no effect on the catalytic activity. This work showed that MOF-74 could be used prospectively as deNO catalyst.

HER2/HER3 dimerization resulting from overexpression of HER2 or neuregulin (NRG1) in cancer leads to HER3-mediated oncogenic activation of PI3K signaling. Although ligand-blocking HER3 antibodies inhibit NRG1-driven tumor growth, they are ineffective against HER2-drive tumor growth because HER2 activates HER3 in a ligand-independent manner. In this study, we describe a novel HER3 monoclonal antibody (LJM716) that can neutralize multiple modes of HER3 activation, making it a superior candidate for clinical translation as a therapeutic candidate. LJM716 was a potent inhibitor of HER3/AKT phosphorylation and proliferation in HER2-amplified and NRG1-expressing cancer cells and it displayed single agent efficacy in tumor xenograft models. Combining LJM716 with agents that target HER2 or EGFR produced synergistic antitumor activity in vitro and in vivo. In particular, combining LJM716 with trastuzumab produced a more potent inhibition of signaling and cell proliferation than trastuzumab/pertuzumab combinations and was similarly active in vivo. To elucidate its mechanism of action, we solved the structure of LJM716 bound to HER3, finding that LJM716 bound to an epitope within domains 2 and 4 that traps HER3 in an inactive conformation. Taken together, our findings establish that LJM716 possesses a novel mechanism of action that in combination with HER2 or EGFR-targeted agents may leverage their clinical efficacy in ErbB-driven cancers.

In flowering plants, pollen tubes are guided into ovules by multiple attractants from female gametophytes to release paired sperm cells for double fertilization. It has been well-established that Ca2+ gradients in the pollen tube tips are essential for pollen tube guidance and that plasma membrane Ca2+ channels in pollen tube tips are core components that regulate Ca2+ gradients by mediating and regulating external Ca2+ influx. Therefore, Ca2+ channels are the core components for pollen tube guidance. However, there is still no genetic evidence for the identification of the putative Ca2+ channels essential for pollen tube guidance. Here, we report that the point mutations R491Q or R578K in cyclic nucleotide-gated channel 18 (CNGC18) resulted in abnormal Ca2+ gradients and strong pollen tube guidance defects by impairing the activation of CNGC18 in Arabidopsis. The pollen tube guidance defects of cngc18-17 (R491Q) and of the transfer DNA (T-DNA) insertion mutant cngc18-1 (+/−) were completely rescued by CNGC18. Furthermore, domain-swapping experiments showed that CNGC18’s transmembrane domains are indispensable for pollen tube guidance. Additionally, we found that, among eight Ca2+ channels (including six CNGCs and two glutamate receptor-like channels), CNGC18 was the only one essential for pollen tube guidance. Thus, CNGC18 is the long-sought essential Ca2+ channel for pollen tube guidance in Arabidopsis.

A series of terpene isonitriles, isolated from marine sponges, have previously been shown to exhibit antimalarial activities. Molecular modeling studies employing 3D-QSAR with receptor modeling methodologies performed with these isonitriles showed that the modeled molecules could be used to generate a pharmacophore hypothesis consistent with the experimentally derived biological activities. It was also shown that one of the modeled compounds, diisocyanoadociane (4), as well as axisonitrile-3 (2), both of which have potent antimalarial activity, interacts with heme (FP) by forming a coordination complex with the FP iron. Furthermore, these compounds were shown to inhibit sequestration of FP into beta-hematin and to prevent both the peroxidative and glutathione-mediated destruction of FP under conditions designed to mimic the environment within the malaria parasite. By contrast, two of the modeled diterpene isonitriles, 7-isocyanoamphilecta-11(20),15-diene (12) and 7-isocyano-15-isothiocyanatoamphilecta-11(20)-ene (13), that displayed little antimalarial activity also showed little inhibitory activity in these FP detoxification assays. These studies suggest that the active isonitrile compounds, like the quinoline antimalarials, exert their antiplasmodial activity by preventing FP detoxification. Molecular dynamics simulations performed with diisocyanoadociane (4) and axisonitrile-3 (2) allowed their different binding to FP to be distinguished.

Herein, we report a deep‐red TADF emitter pCNQ–TPA, composed of quinoxaline‐5,8‐dicarbonitrile (pCNQ) acceptor and triphenylamine (TPA) donor. pCNQ–TPA supported its OLED with desired CIE coordinates of (0.69, 0.31) and the record maximum external quantum efficiency of 30.3 %, which is the best red TADF diode with Rec.2020 gamut for UHDTV. It is showed that through tuning pCNQ–TPA doping concentration, intra‐ and inter‐molecular charge transfer are balanced to synchronously improve emission color saturation and TADF radiation, and remedy aggregation‐induced quenching, rendering photoluminescence quantum yield (PLQY) reaching 90 % for deep‐red emission peaked at ≈690 nm. Quasi‐planar structure further endows pCNQ–TPA with an improved horizontal ratio of emitting dipole orientation, which increases light out‐coupling ratio to 0.34 for achieving the state‐of‐the‐art device efficiencies.

In this article, we successfully prepared the WO 3 /g-C 3 N 4 (WO/CN) heterojunction photocatalyst with high photocatalytic CO 2 reduction performance by the simple impregnation− calcination process. Transmission electron microscopy (TEM) analysis shows that the WO 3 nanoparticles (WO 3 NPs) are successfully attached to the g-C 3 N 4 nanosheets (CN). UV−vis reflectance spectrum (UV−vis DRS), photoluminescence spectrum (PL), and photoelectrochemical (PEC) results confirm that the building of a WO/CN heterojunction is beneficial to the transfer and separation processes of the photogenerated carriers in the photocatalysts. The photoreduction performances of the obtained samples are indicated by the photocatalytic CO 2 reduction process under UV and visible light irradiation. These experiments prove that the 10-WO/CN photocatalyst has the best photoreduction performance compared to other obtained photocatalysts. The yields of CO and CH 4 in the presence of the 10-WO/CN photocatalyst are 8.9 and 47.7 times larger than those of pure CN under UV irradiation. For the irradiation of visible light, the yield rates of CO and CH 4 over 10-WO/CN are 8.6 and 7.5 times greater than those of the CN. On the basis of these photocatalytic results and electron spin resonance (ESR) results, the possible direct Z-scheme electron transfer mechanism for 10-WO/CN with the improved photoreduction CO 2 activity has been discussed.

No abstract